Shoichiro Kanda

989 total citations
36 papers, 442 citations indexed

About

Shoichiro Kanda is a scholar working on Molecular Biology, Nephrology and Rheumatology. According to data from OpenAlex, Shoichiro Kanda has authored 36 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Nephrology and 7 papers in Rheumatology. Recurrent topics in Shoichiro Kanda's work include Renal Diseases and Glomerulopathies (15 papers), Renal and related cancers (11 papers) and Pediatric Urology and Nephrology Studies (4 papers). Shoichiro Kanda is often cited by papers focused on Renal Diseases and Glomerulopathies (15 papers), Renal and related cancers (11 papers) and Pediatric Urology and Nephrology Studies (4 papers). Shoichiro Kanda collaborates with scholars based in Japan, United States and Canada. Shoichiro Kanda's co-authors include Yutaka Harita, Motoshi Hattori, Seisuke Hattori, Kenichiro Miura, Takashi Kanno, Yuko Kajiho, Takashi Igarashi, Takashi Sekine, Kiyonobu Ishizuka and Takafumi Inoue and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Shoichiro Kanda

33 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shoichiro Kanda Japan 13 267 165 72 56 44 36 442
Shogo Minamikawa Japan 15 401 1.5× 159 1.0× 86 1.2× 177 3.2× 43 1.0× 46 708
Ying Maggie Chen United States 13 205 0.8× 202 1.2× 32 0.4× 45 0.8× 83 1.9× 19 541
Nanami Gotoh Japan 10 191 0.7× 136 0.8× 28 0.4× 62 1.1× 58 1.3× 26 483
Naoya Morisada Japan 15 367 1.4× 89 0.5× 70 1.0× 205 3.7× 36 0.8× 46 585
Lynelle K. Jones Australia 14 199 0.7× 58 0.4× 43 0.6× 91 1.6× 24 0.5× 19 522
Yoshimi Nozu Japan 14 412 1.5× 156 0.9× 75 1.0× 146 2.6× 42 1.0× 21 600
Ron Krofft United States 8 213 0.8× 371 2.2× 23 0.3× 129 2.3× 39 0.9× 8 486
Chiyoko N. Inoue Japan 12 292 1.1× 73 0.4× 42 0.6× 45 0.8× 37 0.8× 24 426
Britta George Germany 11 277 1.0× 408 2.5× 31 0.4× 148 2.6× 41 0.9× 20 603
T. Tataranni Italy 10 116 0.4× 61 0.4× 16 0.2× 62 1.1× 39 0.9× 12 342

Countries citing papers authored by Shoichiro Kanda

Since Specialization
Citations

This map shows the geographic impact of Shoichiro Kanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoichiro Kanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoichiro Kanda more than expected).

Fields of papers citing papers by Shoichiro Kanda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoichiro Kanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoichiro Kanda. The network helps show where Shoichiro Kanda may publish in the future.

Co-authorship network of co-authors of Shoichiro Kanda

This figure shows the co-authorship network connecting the top 25 collaborators of Shoichiro Kanda. A scholar is included among the top collaborators of Shoichiro Kanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoichiro Kanda. Shoichiro Kanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shirai, Yoko, Yuko Kajiho, Shoichiro Kanda, et al.. (2025). Treatment of Nephrotic Syndrome With Antinephrin Antibodies Using Plasmapheresis, Rituximab, and Mycophenolate Mofetil. Kidney International Reports. 10(5). 1591–1593. 1 indexed citations
3.
4.
Shirai, Yoko, Kenichiro Miura, Kiyonobu Ishizuka, et al.. (2023). Multi-Institutional Study of Anti-Nephrin Autoantibodies in Post-Transplant Focal Segmental Glomerulosclerosis Recurrence. Journal of the American Society of Nephrology. 34(11S). 306–306.
5.
6.
Shirai, Yoko, Kenichiro Miura, Kiyonobu Ishizuka, et al.. (2023). A multi-institutional study found a possible role of anti-nephrin antibodies in post-transplant focal segmental glomerulosclerosis recurrence. Kidney International. 105(3). 608–617. 46 indexed citations
7.
Miura, Kenichiro, Naoto Kaneko, Taeko Hashimoto, et al.. (2022). Precise clinicopathologic findings for application of genetic testing in pediatric kidney transplant recipients with focal segmental glomerulosclerosis/steroid-resistant nephrotic syndrome. Pediatric Nephrology. 38(2). 417–429. 1 indexed citations
8.
Kajiho, Yuko, Chie Takahashi, Shoichiro Kanda, et al.. (2021). An infant with X‐linked anhidrotic ectodermal dysplasia with immunodeficiency presenting with Pneumocystis pneumonia: A case report. SHILAP Revista de lepidopterología. 9(11). e05093–e05093. 3 indexed citations
9.
Miura, Kenichiro, Shoichiro Kanda, Taeko Hashimoto, et al.. (2021). Response to steroid and immunosuppressive therapies may predict post‐transplant recurrence of steroid‐resistant nephrotic syndrome. Pediatric Transplantation. 26(8). e14103–e14103. 2 indexed citations
10.
Kanda, Shoichiro, et al.. (2021). A case of early onset cystinuria in a 4-month-old girl. CEN Case Reports. 11(2). 216–219. 2 indexed citations
11.
Nakano, Eiji, Yuko Kajiho, Shoichiro Kanda, et al.. (2020). Incomplete cryptic splicing by an intronic mutation of OCRL in patients with partial phenotypes of Lowe syndrome. Journal of Human Genetics. 65(10). 831–839. 5 indexed citations
12.
Kanda, Shoichiro, Y. Yoshioka, Chie Takahashi, et al.. (2020). Rituximab-induced serum sickness in a 6-year-old boy with steroid-dependent nephrotic syndrome. CEN Case Reports. 9(2). 173–176. 3 indexed citations
13.
Udagawa, Tomohiro, Yutaka Harita, Kenichiro Miura, et al.. (2018). Amnionless-mediated glycosylation is crucial for cell surface targeting of cubilin in renal and intestinal cells. Scientific Reports. 8(1). 2351–2351. 27 indexed citations
14.
Kanda, Shoichiro, Shigeru Horita, Takeshi Yanagihara, Akira Shimizu, & Motoshi Hattori. (2016). M-type phospholipase A2 receptor (PLA2R) glomerular staining in pediatric idiopathic membranous nephropathy. Pediatric Nephrology. 32(4). 713–717. 13 indexed citations
15.
Udagawa, Tomohiro, Takeshi Yanagihara, Akira Shimizu, et al.. (2016). Altered expression of Crb2 in podocytes expands a variation of CRB2 mutations in steroid-resistant nephrotic syndrome. Pediatric Nephrology. 32(5). 801–809. 14 indexed citations
16.
Hashimoto, Kazunori, Shoichiro Kanda, Yuko Akioka, et al.. (2015). Gonadal Tumor in Frasier Syndrome: A Review and Classification. Cancer Prevention Research. 8(4). 271–276. 26 indexed citations
17.
Nishiyama, Kei, Kenji Fukushima, Takayuki Miyai, et al.. (2015). SPECT/CT to diagnose pleuroperitoneal communication-associated hydrothorax in peritoneal dialysis. Kidney International. 87(4). 866–866. 7 indexed citations
18.
Harita, Yutaka, Hidetake Kurihara, Hidetaka Kosako, et al.. (2014). Epithelial protein lost in neoplasm modulates platelet-derived growth factor–mediated adhesion and motility of mesangial cells. Kidney International. 86(3). 548–557. 20 indexed citations
19.
Kanda, Shoichiro, Shunsuke Tanigawa, Tomoko Ohmori, et al.. (2014). Sall1 Maintains Nephron Progenitors and Nascent Nephrons by Acting as Both an Activator and a Repressor. Journal of the American Society of Nephrology. 25(11). 2584–2595. 60 indexed citations
20.
Nozu, Kandai, Hiroshi Kaito, Kyoko Kanda, et al.. (2007). Molecular analysis of Patients with Type III Bartter Syndrome : picking up large heterozygous deletions with semi-quantitative PCR. Japanese journal of pediatric nephrology. 20(2). 152–158. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shogo Minamikawa Breakdown of academic impact, for papers by Ying Maggie Chen Breakdown of academic impact, for papers by Nanami Gotoh Breakdown of academic impact, for papers by Naoya Morisada Breakdown of academic impact, for papers by Lynelle K. Jones Breakdown of academic impact, for papers by Yoshimi Nozu Breakdown of academic impact, for papers by Ron Krofft Breakdown of academic impact, for papers by Chiyoko N. Inoue Breakdown of academic impact, for papers by Britta George Breakdown of academic impact, for papers by T. Tataranni
Rankless by CCL
2026